Founder of RxActuator, Medipacs and inventor of the technology. Experienced entrepreneur since the age of 18. Mark has a diverse manufacturing and product development background with hands on experience in all aspects of metal and plastic component design development and commercialization. Over fourteen years experience in polymer chemistry, epoxy and hydrogel design. 14 years of Medical device development experience specifically in molecular hydrogel structures and smart materials. Inventor on 17 issued patents and several more pending patents. Mark is an experienced Principal Investigator on multiple grants and author of several published papers as well as numerous awards for the technology. Mark has significant start-up CEO experience and is now focused on making RxActuator a success with the device that will ultimately turn Medipacs around.
Doug Nutter – Chief Marketing Officer
Doug will manage Product Commercialization of Sales and Marketing, and handle initial Arizona, NM and Texas sales. Doug recently served as Chief Development Officer (CDO) with SynCardia Systems, where he oversaw engineering, product development, research, and program management for the privately-held manufacturer of the world’s first and only FDA approved Total Artificial Heart. Doug led the team through development, manufacturing startup and FDA approval of the only polymer material and heart valves approved for the TAH. he led the team to develop the smaller 50cc TAH for smaller sized patients to complement the current 70cc TAH. He also led the conception of the NextGEN ultra-quiet Freedom® 2 Portable Driver for home use, with significant improvements by design in reliability, and unit-cost reduction. Before being promoted to CDO, Douglas served as Chief Operating Officer (COO) with the company, where he oversaw manufacturing, quality, and engineering. He is President/owner of Aurorapath Advisers, served as Vice President of Optical Research Associates, and General Manager, Electro-Optics Group with Zygo Corporation. Over 23 years at General Electric, Doug held increasing Product and Market management responsibilities, generating over $300 million of annual revenue creation through New Product and New Markets. Doug was President and lead executive of the 50/50 Joint Venture Exatec, LLC, General Electric and Bayer. He has broad market, customer and supply chain success in the US, Europe and Asia across the Automotive, Computer, Business equipment, Medical, Plastics, and Optics sectors. Doug holds a Bachelor of Science degree in Physics from the Massachusetts Institute of Technology.
Rx Actuator’s senior management team, Board of Directors and team of advisors have extensive experience and successful track records introducing novel medical devices and infusion systems that have created meaningful business franchises and established significant value for physicians, patients, employees and shareholders.
Harry George has over 35 years experience in founding, operating and investing in successful rapid growth technology-related companies. He is a co-founder of Solstice Capital. From 1981 to 1989, Mr. George was co-founder, Director, and Vice-President of Finance for Interleaf Inc. During this time Interleaf grew to be a publicly traded company with $100 million in annual revenue. In January 2000, Interleaf was acquired by Broadvision in a stock merger that valued Interleaf at approximately $900 million. Harry has been a Director of a number of private and public companies and is a member of the Investors’ Circle. Harry is a member of the advisory committee of the MBA program at the Eller School of Business of the University of Arizona He received an AB from Bowdoin College.
Jim Utts is an Operating Partner with Roundtable Healthcare Partners located in Lake Forest, IL (www.roundtablehp.com) having joined the firm in 2007. Prior to this, Jim spent 25 plus years in various senior management roles working for Baxter Healthcare where his most recent position was President of Baxter Europe. He has extensive operating experience in intravenous solutions, drug delivery and infusion therapy businesses worldwide.
Mark Banister is the inventor of the RxActuator® pump system and unique polymer actuator materials. He has 5 issued patents and 16 pending patents and has authored several published technical papers on smart polymer materials and devices. Mark has over 30 years of experience in business, product design, polymer chemistry, mechanical engineering, manufacturing and tooling design. Currently the PI on a National Science Foundation STTR Phase II Grant, Mark has been able to leverage over $1M in grant funding into over $3M in angel funding.